Mereo BioPharma Group plc
MREO
$1.74
$0.042.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 500.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00K | -- | -- | -- | -- |
| Cost of Revenue | 132.00K | -- | -- | -- | -- |
| Gross Profit | 368.00K | -- | -- | -- | -- |
| SG&A Expenses | 5.49M | 7.27M | 6.45M | 6.20M | 7.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.25M | 11.02M | 14.70M | 9.15M | 12.45M |
| Operating Income | -9.75M | -11.02M | -14.70M | -9.15M | -12.45M |
| Income Before Tax | -14.62M | -12.89M | -7.05M | -15.00M | -12.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.62M | -12.89M | -7.05M | -15.00M | -12.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.62M | -12.89M | -7.05M | -15.00M | -12.26M |
| EBIT | -9.75M | -11.02M | -14.70M | -9.15M | -12.45M |
| EBITDA | -9.59M | -10.87M | -14.55M | -8.99M | -12.31M |
| EPS Basic | -0.46 | -0.41 | -0.23 | -0.49 | -0.43 |
| Normalized Basic EPS | -0.06 | -0.05 | -0.03 | -0.06 | -0.05 |
| EPS Diluted | -0.46 | -0.41 | -0.23 | -0.49 | -0.43 |
| Normalized Diluted EPS | -0.06 | -0.05 | -0.03 | -0.06 | -0.05 |
| Average Basic Shares Outstanding | 159.89M | 156.86M | 155.01M | 154.03M | 142.35M |
| Average Diluted Shares Outstanding | 31.98M | 31.37M | 31.00M | 30.81M | 28.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |